Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer.

Bass R, Fleshner N, Finelli A, Barkin J, Zhang L, Klotz L.

J Urol. 2019 Jan;201(1):113-119. doi: 10.1016/j.juro.2018.07.040.

PMID:
30577402
2.

Oncologic and functional outcome of partial gland ablation with HIFU for localized prostate cancer.

Bass R, Fleshner N, Finelli A, Barkin J, Zhang L, Klotz L.

J Urol. 2018 Jul 20. pii: S0022-5347(18)43550-1. doi: 10.1016/j.juro.2018.07.040. [Epub ahead of print]

PMID:
30036514
3.

Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.

Crouzet S, Chapelon JY, Rouvière O, Mege-Lechevallier F, Colombel M, Tonoli-Catez H, Martin X, Gelet A.

Eur Urol. 2014 May;65(5):907-14. doi: 10.1016/j.eururo.2013.04.039. Epub 2013 Apr 30.

PMID:
23669165
4.

Pathological, Oncologic and Functional Outcomes of a Prospective Registry of Salvage High Intensity Focused Ultrasound Ablation for Radiorecurrent Prostate Cancer.

Siddiqui KM, Billia M, Arifin A, Li F, Violette P, Chin JL.

J Urol. 2017 Jan;197(1):97-102. doi: 10.1016/j.juro.2016.06.092. Epub 2016 Jul 13.

PMID:
27422297
5.

Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.

Thüroff S, Chaussy C.

J Urol. 2013 Aug;190(2):702-10. doi: 10.1016/j.juro.2013.02.010. Epub 2013 Feb 13.

PMID:
23415962
6.

Comparative Analysis of Partial Gland Ablation and Radical Prostatectomy to Treat Low and Intermediate Risk Prostate Cancer: Oncologic and Functional Outcomes.

Garcia-Barreras S, Sanchez-Salas R, Sivaraman A, Barret E, Secin F, Nunes-Silva I, Linares-Espinós E, Rozet F, Galiano M, Cathelineau X.

J Urol. 2018 Jan;199(1):140-146. doi: 10.1016/j.juro.2017.08.076. Epub 2017 Aug 18.

PMID:
28823768
7.

High Intensity Focused Ultrasound for Radiorecurrent Prostate Cancer: A North American Clinical Trial.

Jones TA, Chin J, Mcleod D, Barkin J, Pantuck A, Marks LS.

J Urol. 2018 Jan;199(1):133-139. doi: 10.1016/j.juro.2017.06.078. Epub 2017 Jun 23.

PMID:
28652121
8.

High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.

Dason S, Wong NC, Allard CB, Hoogenes J, Orovan W, Shayegan B.

Int Braz J Urol. 2018 Mar-Apr;44(2):248-257. doi: 10.1590/S1677-5538.IBJU.2017.0025.

9.
10.

Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.

Inoue Y, Goto K, Hayashi T, Hayashi M.

Int J Urol. 2011 May;18(5):358-62. doi: 10.1111/j.1442-2042.2011.02739.x. Epub 2011 Mar 30.

11.

Can pre- and postoperative magnetic resonance imaging predict recurrence-free survival after whole-gland high-intensity focused ablation for prostate cancer?

Rosset R, Bratan F, Crouzet S, Tonoli-Catez H, Mège-Lechevallier F, Gelet A, Rouvière O.

Eur Radiol. 2017 Apr;27(4):1768-1775. doi: 10.1007/s00330-016-4491-3. Epub 2016 Jul 19.

PMID:
27436018
12.

Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.

Pfeiffer D, Berger J, Gross AJ.

BJU Int. 2012 Dec;110(11):1702-7. doi: 10.1111/j.1464-410X.2012.11375.x. Epub 2012 Aug 29.

13.

Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer.

Kanthabalan A, Peters M, Van Vulpen M, McCartan N, Hindley RG, Emara A, Moore CM, Arya M, Emberton M, Ahmed HU.

BJU Int. 2017 Aug;120(2):246-256. doi: 10.1111/bju.13831. Epub 2017 Apr 3.

14.

Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes.

Crouzet S, Murat FJ, Pommier P, Poissonnier L, Pasticier G, Rouviere O, Chapelon JY, Rabilloud M, Belot A, Mège-Lechevallier F, Tonoli-Catez H, Martin X, Gelet A.

Radiother Oncol. 2012 Nov;105(2):198-202. doi: 10.1016/j.radonc.2012.09.014. Epub 2012 Oct 12.

PMID:
23068708
15.

Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort.

Dickinson L, Arya M, Afzal N, Cathcart P, Charman SC, Cornaby A, Hindley RG, Lewi H, McCartan N, Moore CM, Nathan S, Ogden C, Persad R, van der Meulen J, Weir S, Emberton M, Ahmed HU.

Eur Urol. 2016 Oct;70(4):668-674. doi: 10.1016/j.eururo.2016.02.054. Epub 2016 Mar 4.

PMID:
26951947
16.

HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.

Asimakopoulos AD, Miano R, Virgili G, Vespasiani G, Finazzi Agrò E.

Urol Oncol. 2012 Sep;30(5):577-83. doi: 10.1016/j.urolonc.2010.08.019. Epub 2011 Feb 2.

PMID:
21292508
17.

Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study.

Baco E, Gelet A, Crouzet S, Rud E, Rouvière O, Tonoli-Catez H, Berge V, Chapelon JY, Eggesbø HB.

BJU Int. 2014 Oct;114(4):532-40. doi: 10.1111/bju.12545. Epub 2014 Apr 16.

18.

Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy.

Uddin Ahmed H, Cathcart P, Chalasani V, Williams A, McCartan N, Freeman A, Kirkham A, Allen C, Chin J, Emberton M.

Cancer. 2012 Jun 15;118(12):3071-8. doi: 10.1002/cncr.26631. Epub 2011 Nov 9.

19.

Usefulness of proton magnetic resonance spectroscopy in predicting positive biopsy after high-intensity focused ultrasound for treatment of localized prostate cancer.

Muto S, Kaminaga T, Horiuchi A, Kitamura K, Saito K, Isotani S, Yamaguchi R, Ide H, Furui S, Horie S.

Int J Urol. 2014 Aug;21(8):776-80. doi: 10.1111/iju.12442. Epub 2014 Mar 20.

20.

[Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].

Lu J, Chen ZY, Wang W, Zhang YF, Qiu XF, Zhang LC, Hu WL, Xu WF, Ye ZQ.

Zhonghua Nan Ke Xue. 2007 Nov;13(11):1005-8. Chinese.

PMID:
18077913

Supplemental Content

Support Center